Kazia Therapeutics Limited
KZIA · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | – | $7,812 | $32,083 | $80,603 |
| - Cash | $4,345 | $1,657 | $5,241 | $7,361 |
| + Debt | $0 | $634 | $1,796 | $1,841 |
| Enterprise Value | – | $6,789 | $28,638 | $75,083 |
| Revenue | $42 | $2,308 | $1 | $10 |
| % Growth | -98.2% | 415,755.9% | -94.5% | – |
| Gross Profit | $42 | $2,308 | $1 | $10 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$13,283 | -$26,593 | -$22,277 | -$23,515 |
| % Margin | -31,626.2% | -1,152.2% | -4,013,885.9% | -235,150% |
| Net Income | -$20,702 | -$26,778 | -$20,465 | -$25,014 |
| % Margin | -49,290.5% | -1,160.2% | -3,687,419.8% | -250,140% |
| EPS Diluted | -18.9 | -55 | -55 | -95 |
| % Growth | 65.6% | 0% | 42.1% | – |
| Operating Cash Flow | -$13,278 | -$9,581 | -$15,156 | -$22,762 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$13,278 | -$9,581 | -$15,156 | -$22,762 |